Q2: The Doctor Care Anywhere (ASX:DOC) share price is one to watch

The Doctor Care Anywhere Group PLC (ASX:DOC) share price could be one to watch after announcing another strong quarter of growth.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Doctor Care Anywhere Group PLC (ASX: DOC) share price could be one to watch after announcing another strong quarter of growth.

If you haven’t heard of Doctor Care Anywhere before, it’s a UK-based telehealth business that is looking to provide care through digitally enabled pathways on a platform. It works with a range of health insurers, healthcare providers and corporate customers to connect with patients to deliver a range of telehealth services.

Doctor Care Anywhere Q2 update

online pharmacy purchase cenforce online no prescription

It revealed that its ‘underlying revenue’ was £4.8 million ($8.9 million), up 8.1% on the first quarter of 2021. That also represented a 78.1% increase on the second quarter of 2020 (the prior corresponding period).

Doctor Care Anywhere also revealed some other statistics.

It said there its ‘activated lives’ (the number of people who have signed up for the company’s service and entered their details) had increased 12.7% over the quarter and 90.1% year on year.

The company also achieved a record 2,146 consultations on a single day, up 33% on the previous highest day. It saw record consultation volumes seen across all days of the week at the quarter end, demonstrating continued demand as the UK economy unlocks.

In total, it delivered 89,400 consultations during the quarter, down 1.3% on the first quarter of 2021 due to an anticipated shortage of GPs recalled to do the national vaccination program. However, that was still a 69.1% increase year on year.

A recruitment drive added 71 new GPs to the platform in the second quarter of 2021, bringing the panel to 315. There are a further 100 GPs in the pipeline, which would provide appointment capacity per month of up to 45,000. Further recruitment is underway.

Other highlights

online pharmacy order aciphex without prescription with best prices today in the USA
online pharmacy zovirax buy with best prices today in the USA

The company also said that its diagnostic referral volumes were up 34.4% on the first quarter.

It has strengthened its Nuffield Health partnership with an agreement for unique integrated primary care service.

Doctor Care Anywhere finished the period if £31.5 million of cash, meaning it’s well funded to pursue more growth.

Summary thoughts on Doctor Care Anywhere and the share price

The business is expecting FY21 revenue to at least double compared to FY20. That’s a very strong increase in my opinion. If it can continue a high double digit revenue growth rate then Doctor Care Anywhere could certainly be one to watch. Digitally-enabled ways of doing things could be a good growth area. Think about how strongly digital retail is growing.

It’s one of the ASX growth shares on my watchlist.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.